CAREDX, INC. (CDNA) FY2026 Q2 P&L / Income Statement

CAREDX, INC. (CDNA) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Segments by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenue

131,948,000 US dollars

Cost of revenue (calculated)

34,966,000 US dollars

Gross profit (calculated)

96,982,000 US dollars

Operating expenses (calculated)

negative 16,241,000 US dollars

Income (loss) from operations

113,223,000 US dollars

Total other income

1,295,000 US dollars

Income (loss) before income taxes

114,518,000 US dollars

Income tax (expense) benefit

3,882,000 US dollars

Net income (loss)

110,636,000 US dollars

Reportable Segment - Patient and digital solutions revenue

19,230,000 US dollars

Reportable Segment - Product revenue

12,791,000 US dollars

Reportable Segment - Testing services revenue

99,927,000 US dollars

Cost of testing services, product, patient and digital solutions

34,966,000 US dollars

Research and development

22,376,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.

Sales and marketing

33,441,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.

General and administrative

40,908,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.

Litigation settlement expense

0 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.